854778-42-0

Basic information

• Product Name: 4-bromo-1-(bromomethyl)-2-methoxybenzene
• Synonyms: 4-bromo-1-(bromomethyl)-2-methoxybenzene;4-Bromo-2-methoxybenzyl bromide;Benzene, 4-bromo-1-(bromomethyl)-2-methoxy-
• CAS NO: 854778-42-0
• Molecular Formula: C8H8Br2O
• Molecular Weight: 279.95652
• Mol File: 854778-42-0.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-bromo-1-(bromomethyl)-2-methoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-1-(bromomethyl)-2-methoxybenzene(854778-42-0)
• EPA Substance Registry System: 4-bromo-1-(bromomethyl)-2-methoxybenzene(854778-42-0)

Safety Data

• Hazardous Substances Data: 854778-42-0(Hazardous Substances Data)

Usage

General Description

4-bromo-1-(bromomethyl)-2-methoxybenzene is a chemical compound with the molecular formula C8H8Br2O. It is also known by its CAS number 21956-70-7. 4-bromo-1-(bromomethyl)-2-methoxybenzene is a derivative of benzene and contains two bromine atoms, a methoxy group, and a methyl group. It is commonly used in organic synthesis and can be utilized as an intermediate in the production of pharmaceuticals, agrochemicals, and other organic compounds. 4-bromo-1-(bromomethyl)-2-methoxybenzene has potential applications in various industries and research fields due to its unique chemical structure and reactivity.

InChI:InChI=1S/C8H8Br2O/c1-11-8-4-7(10)3-2-6(8)5-9/h2-4H,5H2,1H3

Upstream product

• 67868-73-9 5-bromo-2-methylphenol methyl ether 
• 36138-76-8 5-bromo-2-methylphenol 
• 139102-34-4 methyl 4-bromo-2-methoxybenzoate 
• 17102-63-5 (4-bromo-2-methoxyphenyl)methanol 
• 50-00-0 formaldehyd 
• 2398-37-0 3-methoxyphenyl bromide 

Relevant articles and documents

BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS

The present invention relates to compounds of general formula (I), wherein the groups R1 and R2 are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.

COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS

The invention provides compounds of formula (I), immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat diseases or disorders associated with Toll-Like Receptor 7 activity.

TRIAZOLONE COMPOUNDS AND USES THEREOF

The invention disclosed herein is directed to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections. The invention disclosed herein is also directed to a methods of preventing the onset of and/or recurrence of acute and chronic myeloid leukemia, as well as other cancers, comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist.